Alembic Pharmaceuticals Market Cap ($2.31B USD)
Alembic Pharmaceuticals Market Cap ($2.31B USD). As of Nov. 19, 2026, Alembic Pharmaceuticals (APLLTD) market capitalisation is ₹20778.69 Cr ($2.31B), with 19.80 Cr shares outstanding at a current price of ₹1049.60 on NSE, ranking 353 out of 5368 companies by market cap in our screener. Alembic Pharmaceuticals operates in the Healthcare sector and is classified as a Large Cap stock. For live price, earnings and the complete company profile, see APLLTD share price screener.
Market Cap History of Alembic Pharmaceuticals (Last 10 Years)
APLLTD market capitalisation from year-end NSE closing prices over the last 10 years. Review APLLTD earnings valuation to evaluate earnings-based valuation against sector peers.
End of Year Market Cap History — Alembic Pharmaceuticals
APLLTD year-end market cap in INR and USD with closing share price and annual change — NSE closing prices.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹20778.69 Cr
$2.31B USD
|
₹1049.60 | NSE | +24.04% |
| 2025 |
₹16751.04 Cr
$1.86B USD
|
₹846.15 | NSE | -20.64% |
| 2024 |
₹21108.31 Cr
$2.35B USD
|
₹1066.25 | NSE | +40.41% |
| 2023 |
₹15033.67 Cr
$1.67B USD
|
₹759.40 | NSE | +32.55% |
| 2022 |
₹11341.57 Cr
$1.26B USD
|
₹572.90 | NSE | -28.56% |
| 2021 |
₹15875.03 Cr
$1.76B USD
|
₹801.90 | NSE | -22.43% |
| 2020 |
₹20464.91 Cr
$2.27B USD
|
₹1033.75 | NSE | +80.95% |
| 2019 |
₹11309.89 Cr
$1.26B USD
|
₹571.30 | NSE | -4.74% |
| 2018 |
₹11872.12 Cr
$1.32B USD
|
₹599.70 | NSE | +13.02% |
| 2017 |
₹10504.17 Cr
$1.17B USD
|
₹530.60 | NSE | -10.84% |
| 2016 |
₹11781.06 Cr
$1.31B USD
|
₹595.10 | NSE | -14.50% |
| 2015 |
₹13779.54 Cr
$1.53B USD
|
₹696.05 | NSE | +56.36% |
| 2014 |
₹8812.53 Cr
$979.17M USD
|
₹445.15 | NSE | +110.87% |
| 2013 |
₹4179.10 Cr
$464.34M USD
|
₹211.10 | NSE | +191.17% |
| 2012 |
₹1435.27 Cr
$159.47M USD
|
₹72.50 | NSE | +104.51% |
| 2011 |
₹701.80 Cr
$77.98M USD
|
₹35.45 | NSE | - |